Supernus Pharmaceuticals | SUPN - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Aurora Cannabis CAD 66.93M 79M 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Cara Therapeutics USD 11.26M 216K 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Eisai JPY 393.64B 53.39B 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Novo Nordisk DKK 239.08B 13.92B 2026-06
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06